Skip to content

RiethPharma: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

RiethPharma

BE 0824.514.648
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€9,947
2024 · -€6,024+€15,972
Equity
€68,481
2024 · €58,534+€9,947
Cash
€2,576
2024 · €4,874-€2,298
Balance sheet total
€138,933
2024 · €113,869+€25,064

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€26,525

    up €26,525 (+56.9%), from €46,625 to €73,150

    of which Trade receivables: +€17,028

  • Cash -€2,298

    down €2,298 (-47.1%), from €4,874 to €2,576

    mainly Receivables within one year (-€26,525) and Stocks and contracts (-€1,500)

  • Stocks and contracts +€1,500

    up €1,500 (+3.0%), from €49,725 to €51,225

Equity and liabilities
  • Trade debts +€14,915

    up €14,915 (+44.3%), from €33,694 to €48,610

  • Reserves +€9,947

    up €9,947 (+24.9%), from €39,984 to €49,931

Income statement
  • Staff costs -€34,376

    down €34,376 (-100.0%), from €34,376 to €0

  • Gross operating margin -€16,688

    down €16,688 (-50.1%), from €33,315 to €16,627

  • Financial charges +€1,545

    up €1,545 (+39.5%), from €3,906 to €5,450

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€6,024
Gross operating margin -€16,688
Staff costs +€34,376
Depreciation -€167
Other operating charges -€5
Financial charges -€1,545
Result 2025 €9,947

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€2,645
Investment €0
Financing +€347
Cash 2024 €4,874
Net result for the year +€9,947
Depreciation +€1,021
Stocks and contracts -€1,500
Receivables within one year -€26,525
Deferred charges and accrued income -€359
Trade debts +€14,915
Other debts +€40
Accrued charges and deferred income -€186
Short-term financial debts +€347
Cash 2025 €2,576
Every line side by side 37 lines
Line Code 2024 2025 Change %
Total assets 20/58 €113,869 €138,933 +€25,064 +22.0%
Fixed assets 21/28 €4,020 €2,999 -€1,021 -25.4%
Tangible fixed assets 22/27 €4,020 €2,999 -€1,021 -25.4%
Plant, machinery and equipment 23 €4,020 €2,999 -€1,021 -25.4%
Current assets 29/58 €109,848 €135,934 +€26,086 +23.7%
Stocks and contracts in progress 3 €49,725 €51,225 +€1,500 +3.0%
Stocks 30/36 €49,725 €51,225 +€1,500 +3.0%
Amounts receivable within one year 40/41 €46,625 €73,150 +€26,525 +56.9%
Trade receivables 40 €41,830 €58,859 +€17,028 +40.7%
Other amounts receivable 41 €4,795 €14,292 +€9,497 +198.0%
Cash at bank and in hand 54/58 €4,874 €2,576 -€2,298 -47.1%
Deferred charges and accrued income 490/1 €8,624 €8,983 +€359 +4.2%
Total equity and liabilities 10/49 €113,869 €138,933 +€25,064 +22.0%
Equity 10/15 €58,534 €68,481 +€9,947 +17.0%
Contributions 10/11 €18,550 €18,550 = 0.0%
Reserves 13 €39,984 €49,931 +€9,947 +24.9%
Distributable reserves 133 €39,984 €49,931 +€9,947 +24.9%
Amounts payable 17/49 €55,335 €70,452 +€15,117 +27.3%
Amounts payable within one year 42/48 €53,730 €69,032 +€15,303 +28.5%
Financial debts 43 €0 €347 +€347
Credit institutions 430/8 €0 €347 +€347
Trade debts 44 €33,694 €48,610 +€14,915 +44.3%
Suppliers 440/4 €33,694 €48,610 +€14,915 +44.3%
Taxes, remuneration and social security 45 €0 - =
Remuneration and social security 454/9 €0 - =
Other amounts payable 47/48 €20,035 €20,075 +€40 +0.2%
Accrued charges and deferred income 492/3 €1,605 €1,420 -€186 -11.6%
Remuneration, social security and pensions 62 €34,376 €0 -€34,376 -100.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €854 €1,021 +€167 +19.6%
Other operating charges 640/8 €203 €208 +€5 +2.3%
Gross operating margin 9900 €33,315 €16,627 -€16,688 -50.1%
Operating profit (loss) 9901 -€2,119 €15,398 +€17,516
Financial charges 65/66B €3,906 €5,450 +€1,545 +39.5%
Recurring financial charges 65 €3,906 €5,450 +€1,545 +39.5%
Profit (loss) for the period before taxes 9903 -€6,024 €9,947 +€15,972
Profit (loss) for the period 9904 -€6,024 €9,947 +€15,972
Profit (loss) for the period to be appropriated 9905 -€6,024 €9,947 +€15,972

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.